Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules
Sign Up to like & getrecommendations! Published in 2018 at "Chest"
DOI: 10.1016/j.chest.2018.02.012
Abstract: BACKGROUND: Lung nodules are a diagnostic challenge, with an estimated yearly incidence of 1.6 million in the United States. This study evaluated the accuracy of an integrated proteomic classifier in identifying benign nodules in patients… read more here.
Keywords: lung; lung nodules; integrated classifier; benign nodules ... See more keywords